논문KCI 등재
Letter by Awadhesh Kumar Singh Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis”
0
조회
0
다운로드
0
인용
0
참고문헌
참고문헌 (3)
- 전원경, "Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis", 지질·동맥경화학회지, 10(2), pp.210~222 (2021), 한국지질동맥경화학회[DOI]
- Bain S, "Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs : a Bayesian meta-analysis of survival data", Diabetes Obes Metab, 19, pp.329~335 (2017)
- Rosenstock J, "Effect of Linagliptin vs glimepiride on major adverse cardiovascular outcomes in patients with type 2 diabetes : the CAROLINA randomized clinical trial", JAMA, 322, pp.1155~1166 (2019)
관련 논문AI추천
Response to Letter Regarding Article, “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis”Park Kyung Woo한국지질동맥경화학회 · 지질·동맥경화학회지2022 · 제11권 제1호Correction to: “Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: A Meta-Analysis”전원경, Kang Jeehoon, Kim Hyo-Soo, Park Kyung Woo한국지질동맥경화학회 · 지질·동맥경화학회지2022 · 제11권 제1호Cardiovascular Outcomes Comparison of Dipeptidyl Peptidase-4 Inhibitors versus Sulfonylurea as Add-on Therapy for Type 2 Diabetes Mellitus: a Meta-Analysis강지훈, 김효수, 박경우, 전원경한국지질동맥경화학회 · 지질·동맥경화학회지2021 · 제10권 제2호Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes강은석, 김영은, 배재현, 이민영, 이병완, 이용호, 차봉수연세대학교의과대학 · Yonsei Medical Journal2022 · 제63권 제6호Correspondence to editorial on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”Hayeon Kim, Kyungim Kim, Min Jeong Park, Myeong Gyu Kim대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Cardiovascular Outcome Trials of Incretin Therapy (Dipeptidyl Peptidase-4 Inhibitors/Glucagon-Like Peptide-1 Receptor Agonist)정인경한국지질동맥경화학회 · 지질·동맥경화학회지2018 · 제7권 제1호
이 간행물의 다른 논문 (7건)
SGLT2 Inhibitors and Ketone Metabolism in Heart FailureWestenbrink B. Daan, Yurista Salva R., de Boer Rudolf A., Voorrips Suzanne N., Saucedo-Orozco Huitzilihuitlpp. 1-19Metabolism and Health Impacts of Dietary SugarsKim Raymond, Jang Cholsoon, Alam Yasmine Hennapp. 20-38Individualized Treatment for Patients With Familial HypercholesterolemiaTada Hayato, Takamura Masayuki, Kawashiri Masa-akipp. 39-54Profiling of RNA-binding Proteins Interacting With Glucagon and Adipokinetic Hormone mRNAsYoon Je-Hyun, Lee Kyu-Sun, Delaney Joe R., Chun Yoo Lim, Mun Hyejin, Howard-McGuire Marina, Millison Nathan T., Lee Kwang-Pyo, Lee Changhan, Ko Seungbeom, 정준양, 염은별pp. 55-72Assessing the Validity of the Criteria for the Extreme Risk Category of Atherosclerotic Cardiovascular Disease: A Nationwide Population-Based StudyHan Kyungdo, 박철영, 김경수, Hong Sangmopp. 73-83